![Magnus Persson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Magnus Persson
Chairman at Trailhead Biosystems, Inc.
Magnus Persson active positions
Companies | Position | Start | End |
---|---|---|---|
Trailhead Biosystems, Inc.
![]() Trailhead Biosystems, Inc. Medical SpecialtiesHealth Technology Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH. | Chairman | - | - |
Strike Pharma AB
![]() Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Director/Board Member | - | - |
Career history of Magnus Persson
Statistics
International
United States | 2 |
Sweden | 2 |
Operational
Chairman | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Trailhead Biosystems, Inc.
![]() Trailhead Biosystems, Inc. Medical SpecialtiesHealth Technology Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH. | Health Technology |
Strike Pharma AB
![]() Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
- Stock Market
- Insiders
- Magnus Persson
- Experience